Adrenoceptor-mediated enhancement of interleukin-33 production by dendritic cells

Brain, Behavior, and Immunity

Volumn 25, Issue 7, 2011, Pages 1427-1433

  Yanagawa, Yoshiki ^a   Matsumoto, Machiko ^a   Togashi, Hiroko ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

2 adrenoceptor; Cyclic amp; Dendritic cells; Interleukin 33; Protein kinase a

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ADRENALIN; ADRENERGIC RECEPTOR; CYCLIC AMP; INTERLEUKIN 33; LIPOPOLYSACCHARIDE; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NORADRENALIN; SALMETEROL;

ALLERGIC DISEASE; ANIMAL CELL; ARTICLE; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNITY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TH2 CELL;

ADRENERGIC AGENTS; ALBUTEROL; ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; EPINEPHRINE; INTERLEUKINS; LIPOPOLYSACCHARIDES; MICE; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, BETA-2; RNA, MESSENGER;

EID: 80052710228     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.04.012     Document Type: Article

References (46)

1. Ali S., Huber M., Kollewe C., Bischoff S.C., Falk W., Martin M.U. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl. Acad. Sci. USA 2007, 104:18660-18665.
2. Baker J.G. The selectivity of β-adrenoceptor agonists at human β1-, β2- and β3-adrenoceptors. Br. J. Pharmacol. 2010, 160:1048-1061.
3. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-251.
4. Cayrol C., Girard J.P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. USA 2009, 106:9021-9026.
5. Chackerian A.A., Oldham E.R., Murphy E.E., Schmitz J., Pflanz S., Kastelein R.A. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 2007, 179:2551-2555.
6. Cherry W.B., Yoon J., Bartemes K.R., Iijima K., Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 2008, 121:1484-1490.
7. Chida Y., Steptoe A., Hirakawa N., Sudo N., Kubo C. The effects of psychological intervention on atopic dermatitis. A systematic review and meta-analysis. Int. Arch. Allergy Immunol. 2007, 144:1-9.
8. Chrousos G.P. Stress and disorders of the stress system. Nat. Rev. Endocrinol. 2005, 5:374-381.
9. Davis E., Loiacono R., Summers R.J. The rush to adrenaline: drugs in sport acting on the β-adrenergic system. Br. J. Pharmacol. 2008, 154:584-597.
10. Docherty J.R. Subtypes of functional α1-adrenoceptor. Cell. Mol. Life Sci. 2010, 67:405-417.
11. Felten D.L., Felten S.Y., Carlson S.L., Olschowka J.A., Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 1985, 135(2 Suppl):755s-765s.
12. Franco R., Pacheco R., Lluis C., Ahern G.P., O'Connell P.J. The emergence of neurotransmitters as immune modulators. Trends Immunol. 2007, 28:400-407.
13. Glaser R., Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 2005, 5:243-251.
14. Goyarts E., Matsui M., Mammone T., Bender A.M., Wagner J.A., Maes D., Granstein R.D. Norepinephrine modulates human dendritic cell activation by altering cytokine release. Exp. Dermatol. 2008, 17:188-196.
15. Gyires K., Zádori Z.S., Török T., Mátyus P. α2-Adrenoceptor subtypes-mediated physiological, pharmacological actions. Neurochem. Int. 2009, 55:447-453.
16. Haczku A., Panettieri R.A. Social stress and asthma: the role of corticosteroid insensitivity. J. Allergy Clin. Immunol. 2010, 125:550-558.
17. Hart D.N.J. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997, 90:3245-3287.
18. Hsu C.L., Neilsen C.V., Bryce P.J. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One 2010, 5:e11944.
19. Imler J.L., Hoffmann J.A. Toll signaling: the TIReless quest for specificity. Nat. Immunol. 2003, 4:105-106.
20. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992, 176:1693-1702.
21. Liu K., Nussenzweig M.C. Development and homeostasis of dendritic cells. Eur. J. Immunol. 2010, 40:2099-2102.
22. Kawai T., Akira S. Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 2005, 17:338-344.
23. Kawakami K., Nagatomo T., Abe H., Kikuchi K., Takemasa H., Anson B.D., Delisle B.P., January C.T., Nakashima Y. Comparison of HERG channel blocking effects of various β-blockers - implication for clinical strategy. Br. J. Pharmacol. 2006, 147:642-652.
24. Koff W.C., Fann A.V., Dunegan M.A., Lachman L.B. Catecholamine-induced suppression of interleukin-1 production. Lymphokine Res. 1986, 5:239-247.
25. Kurowska-Stolarska M., Stolarski B., Kewin P., Murphy G., Corrigan C.J., Ying S., Pitman N., Mirchandani A., Rana B., van Rooijen N., Shepherd M., McSharry C., McInnes I.B., Xu D., Liew F.Y. IL-33 induces antigenspecific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J. Immunol. 2009, 181:4780-4790.
26. Liew F.Y., Pitman N.I., McInnes I.B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 2010, 10:103-110.
27. Lüthi A.U., Cullen S.P., McNeela E.A., Duriez P.J., Afonina I.S., Sheridan C., Brumatti G., Taylor R.C., Kersse K., Vandenabeele P., Lavelle E.C., Martin S.J. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
28. Maestroni G.J. Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development. J. Neuroimmunol. 2002, 129:106-114.
29. Maestroni G.J., Mazzola P. Langerhans cells β2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity. J. Neuroimmunol. 2003, 144:91-99.
30. Nile C.J., Barksby E., Jitprasertwong P., Preshaw P.M., Taylor J.J. Expression and regulation of interleukin-33 in human monocytes. Immunology 2010, 130:172-180.
31. Ohno T., Oboki K., Kajiwara N., Morii E., Aozasa K., Flavell R.A., Okumura K., Saito H., Nakae S. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J. Immunol. 2009, 183:7890-7897.
32. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signaling. Nat. Rev. Immunol. 2007, 7:353-364.
33. Pecaric-Petkovic T., Didichenko S.A., Kaempfer S., Spiegl N., Dahinden C.A. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009, 113:1526-1534.
34. Préfontaine D., Lajoie-Kadoch S., Foley S., Audusseau S., Olivenstein R., Halayko A.J., Lemière C., Martin J.G., Hamid Q. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 2009, 183:5094-5103.
35. Pushparaj P.N., Tay H.K., H'ng S.C., Pitman N., Xu D., McKenzie A., Liew F.Y., Melendez A.J. The cytokine interleukin-33 mediates anaphylactic shock. Proc. Natl. Acad. Sci. USA 2009, 106:9773-9778.
36. Rehmann H., Arias-Palomo E., Hadders M.A., Schwede F., Llorca O., Bos J.L. Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B. Nature 2008, 455:124-127.
37. Salpeter S.R., Buckley N.S., Ormiston T.M., Salpeter E.E. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann. Intern. Med. 2006, 144:904-912.
38. Schmid A., Sutto Z., Schmid N., Novak L., Ivonnet P., Horvath G., Conner G., Fregien N., Salathe M. Decreased soluble adenylyl cyclase activity in cystic fibrosis is related to defective apical bicarbonate exchange and affects ciliary beat frequency regulation. J. Biol. Chem. 2010, 285:29998-30007.
39. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D.M., Bazan J.F., Kastelein R.A. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
40. Smith D.E. The biological paths of IL-1 family members IL-18 and IL-33. J. Leukoc. Biol. 2011, 89:383-392.
41. Steinman R. The dendritic cell system, its role in immunogenicity. Annu. Rev. Immunol. 1991, 9:271-296.
42. Takahashi H.K., Zhang J., Mori S., Liu K., Wake H., Liu R., Sadamori H., Matsuda H., Yagi T., Yoshino T., Nishibori M. Prostaglandin E2 inhibits advanced glycation end product-induced adhesion molecule expression on monocytes, cytokine production, and lymphocyte proliferation during human mixed lymphocyte reaction. J. Pharmacol. Exp. Ther. 2010, 334:964-972.
43. Yamazaki S., Bonito A.J., Spisek R., Dhodapkar M., Inaba K., Steinman R.M. Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+CD4+ regulatory T cells from peripheral Foxp3 precursors. Blood 2007, 110:4293-4302.
44. Yanagawa Y., Matsumoto M., Togashi H. Enhanced dendritic cell antigen uptake via α2 adrenoceptor-mediated PI3K activation following brief exposure to noradrenaline. J. Immunol. 2010, 185:5762-5768.
45. Yuan J.S., Reed A., Chen F., Stewart C.N. Statistical analysis of real-time PCR data. BMC Bioinformat. 2006, 7:85.
46. Zinyama R.B., Bancroft G.J., Sigola L.B. Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-α and interleukin-10. Immunology 2010, 104:439-446.